• Home
• Health And Medicine
• Medications for Alcohol Use Disorder: How They Reduce Relapse Risk - and When They Don’t

Medications for Alcohol Use Disorder: How They Reduce Relapse Risk - and When They Don’t

When someone is trying to stop drinking, the hardest part isn’t always willpower - it’s the brain chemistry that keeps screaming for alcohol. Medications can help silence that noise. But here’s the truth most people don’t talk about: alcohol use disorder medications work only if they’re used right. Take them with alcohol? You could end up in the ER. Skip doses? Your risk of relapse shoots back up. And if you’re not matched to the right drug? It might do nothing at all.

How These Drugs Actually Work

There are three FDA-approved medications for alcohol use disorder, each with a different job. They don’t cure addiction. They don’t make you stop wanting to drink. They change how your brain reacts - and that’s enough to keep many people from going back to heavy drinking.

Naltrexone blocks the part of your brain that gets rewarded when you drink. Think of it like turning off the pleasure button. You still might take a sip, but it doesn’t feel good anymore. That cuts down on heavy drinking episodes. A 2021 meta-analysis found oral naltrexone (50 mg daily) reduced relapse risk by 18% compared to placebo. The monthly shot, Vivitrol, works the same way - but you don’t have to remember to take it every day.

Acamprosate fixes the brain chaos after you stop drinking. Alcohol messes with your neurotransmitters - especially GABA and glutamate. When you quit, your brain doesn’t know how to calm down. Acamprosate helps restore balance. It’s not about stopping cravings. It’s about making life feel normal again after detox. People who’ve been sober for a few days and want to stay that way often do best with this one.

Disulfiram is the old-school option. It makes your body react badly to alcohol - flushing, nausea, pounding heart. It’s not a treatment. It’s a deterrent. You have to be scared of drinking for it to work. And if you’re not? You’ll just stop taking it. Still, for some people - highly motivated, with strong support - it’s the only thing that keeps them sober.

Who Gets the Best Results?

Not everyone responds the same way. Your history matters more than you think.

If you’ve had severe withdrawal symptoms - seizures, hallucinations, delirium - gabapentin might be your best bet. A 2020 study showed 45% of people with high withdrawal symptoms stayed abstinent on gabapentin. Only 28% did on placebo. That’s a big difference. Gabapentin is also safer for people with liver disease, which is huge since many with AUD have damaged livers.

If your goal is total abstinence, acamprosate is the go-to. If you just want to cut back on binge drinking, naltrexone wins. Disulfiram? Only if you’re ready to live in fear of a single sip.

And here’s something no one tells you: timing matters. You can’t start acamprosate until you’ve been alcohol-free for 3-5 days. Naltrexone? You need to wait 7-10 days after your last opioid use - even if you’re not addicted to opioids. Some pain meds, cough syrups, even certain anti-diarrhea pills can trigger a dangerous reaction. Your doctor needs to know everything you’re taking.

The Real Problem: People Stop Taking Them

The science is solid. But in real life? Only 34% of people stay on their medication past three months.

Why? Side effects. Cost. And confusion.

Acamprosate causes diarrhea in about 1 in 10 people. Naltrexone? Nausea, mostly. It’s mild, but enough to make someone quit. Disulfiram? Metallic taste, drowsiness, anxiety - and the fear that if you accidentally drink even a little (mouthwash, vanilla extract, fermented foods), you’ll get sick. That fear alone makes people stop.

Cost is another silent killer. Naltrexone and acamprosate cost $200-$400 a month. Even with insurance, copays add up. Disulfiram? $20 a month. But it’s the least prescribed. Why? Doctors are scared of it. And patients don’t trust it.

And here’s the kicker: most primary care doctors don’t feel trained to prescribe these drugs. SAMHSA says only 28% of them do. So patients get sent to specialists - and wait months. By then, the motivation’s gone.

What Happens If You Drink While on These Drugs?

This is where people get hurt.

With naltrexone? You might not feel the high. That’s it. No danger. Just disappointment.

With acamprosate? Nothing dangerous. You might feel more anxious. But no physical reaction.

With disulfiram? That’s the emergency room. If you drink while on it, your body can’t break down alcohol. Acetaldehyde builds up. You get severe flushing, vomiting, chest pain, low blood pressure. In rare cases, it can be fatal. That’s why doctors spend 20 minutes explaining it - and why so many patients still end up in the ER.

And yes - it happens. People drink a glass of wine. Or take a sip of cocktail. Or use hand sanitizer. And then they panic. They don’t tell their doctor. They quit the meds. And relapse follows.

Combining Medications? Not Always Better

You might think: if one drug helps, two must be better. Not always.

The COMBINE study - one of the largest ever on AUD treatment - gave 1,383 people either naltrexone, acamprosate, both, or neither. The result? Taking both together didn’t improve outcomes over taking just one. In fact, it increased side effects without adding benefit.

But another study of 250 people found combination therapy worked better than placebo - and better than acamprosate alone. So what’s the truth? It depends on the person. If you’ve tried one drug and failed, trying another might help. But stacking them? Don’t assume it’s the answer.

What’s New? The Future of Treatment

The field is changing fast.

There’s now a compacted acamprosate pill - down from six a day to two. That’s huge for adherence.

Long-acting naltrexone implants - six-month doses - are in phase 2 trials. Early results show 78% adherence versus 42% for monthly shots. That could change everything.

And then there’s personalized medicine. A 2023 machine learning model used brain scans, genetics, and drinking patterns to match patients to the right drug with 82% accuracy. That’s not science fiction. It’s happening now.

Ketamine infusions? A 2022 study showed a 41% drop in relapse. Microbiome treatments? Lactobacillus and NAC reduced heavy drinking days by 37% in a small trial. These aren’t cures - but they’re new tools.

And digital tools? Apps that track cravings and send alerts when you’re at risk? One 2023 study showed they cut relapse risk by 33% when paired with medication.

What Should You Do?

If you’re trying to stop drinking:

• Don’t assume one size fits all. Your history, your liver health, your motivation - they all matter.
• Ask your doctor: which medication fits me? Not what worked for someone else.
• Be honest about your drinking. Even one drink a week can affect your treatment.
• Know the side effects. If you get diarrhea on acamprosate, don’t quit. Talk to your doctor. Maybe it’s temporary.
• Don’t wait for perfection. If you miss a dose, don’t give up. Just get back on track.
• Combine meds with therapy. Medication alone is half the battle. Counseling, support groups, lifestyle changes - they’re the other half.

Alcohol use disorder isn’t a moral failure. It’s a medical condition. And like diabetes or hypertension, it often needs ongoing treatment. The drugs exist. The evidence is clear. The gap isn’t in science - it’s in access, understanding, and stigma.

You don’t need to be perfect. You just need to keep trying.